You are hereHome >
Campaign for Health Care Reform
DEFENDING REFORMS FROM BIG PHARMA—MASSPIRG Legislative Director Deirdre Cummings, alongside State Sen. Mark Montigny (New Bedford), urges lawmakers to keep the Rx Gift Ban in place. MASSPIRG is committed to helping keep health costs down for consumers.
BEING A WATCHDOG ON HEALTH CARE REFORM
America’s health care system is structured to profit the drug industry, insurance companies, and medical specialists, not better health outcomes for you.
The Affordable Care Act was an historic step toward getting health care costs under control, but more needs to be done to protect its solvency as demographics change and costs continue to rise. We can do this without undermining the fundamental goal of ensuring all Americans have access to quality, affordable health care.
In Massachusetts, which paved the path for the federal law with our 2006 reforms, our priority now is to make sure state leaders focus on how on to deliver lower costs and better quality for consumers.
The cost of inaction to Massachusetts’ families would be overwhelming:
• If we don’t get our leaders to squeeze out the health care system's costly inefficiencies, the full cost of premiums will climb to $26,069 for families and $8,845 for individual employer-sponsored insurance by 2016.
• With these projected increases, the cost of a family health insurance policy will be equal to 41.2% of median household income.
To ensure Massachusetts continues to develop leading models of reform, MASSPIRG joined Campaign for Better Care, a broad coalition of organizations to tackle some of the biggest challenges left in health reform — lowering the cost while promoting more coordinated, efficient and better care.
King Bio Inc. issued the second significant voluntary recall since late July of their homeopathic drugs on Wednesday. Safety concerns over homeopathic drugs extend beyond King Bio as over the past several years, the FDA has issued recalls to several companies for a variety of health products from zinc-containing intranasal medicine to asthma drugs with toxic ingredients.
New executive order on antibiotics takes several important steps necessary to control the spread of antibiotic-resistant bacteria, it misses the opportunity to call for critical reforms in the agricultural sector that are essential to protect public health.
As outlined in our new report entitled Weak Medicine: Why the FDA's New Guidelines Are Inadequate To Curb Antibiotic Resistance and Protect Public Health. Guidelines issued by FDA last year lack the restrictions necessary to fully combat the increase in antibiotic-resistant bacteria documented by world health experts.
As outlined in our new report, Weak Medicine: Why the FDA's New Guidelines Are Inadequate To Curb Antibiotic Resistance and Protect Public Health. Guidelines issued by the FDA last year lack the restrictions necessary to fully combat the increase in antibiotic-resistant bacteria documents by world health experts.
When it comes to health care, there are few magic-bullet solutions for the many problems consumers face in the marketplace: insurers don’t compete for their business, leading to higher prices and lower quality. Important information about coverage is buried in the fine print, making it hard to know what’s really covered or which plan is right. And costs are continuing their unsustainable rise.
Tools & Resources
Your donation supports MASSPIRG's work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.